2025 Labelling Pharmaceutical Companies 
European Pharmaceutical Review
NOVEMBER 1, 2024
The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.
European Pharmaceutical Review
MARCH 27, 2025
As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. 1 Figure 1 : Costs for UK skilled worker visa compared to those of other leading science nations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 7, 2023
Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson.
The Checkup by Singlecare
MARCH 10, 2025
Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. If your healthcare provider prescribes Ozempic for weight management, which is an off-label use, insurance isnt as likely to cover it. For those licensed by the state, the deadline is April 22, 2025.
The Thyroid Pharmacist
NOVEMBER 29, 2023
This is because I had learned about various adulterants found in supplements, how some supplement manufacturers don’t actually put the products that are on the label in the bottle, or that the dosages listed on the label may be completely different from what’s in the products. We have 270 expiring in March 2025.)
The Checkup by Singlecare
FEBRUARY 10, 2025
The pharmaceutical company Prasco currently markets a generic version of Farxiga. Additionally, several other companies have tentative FDA approvals, meaning that their generic versions have met the requirements for FDA approval but cannot yet be marketed in the United States due to patent issues.
pharmaphorum
JANUARY 14, 2021
Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Whatever the challenges, the pharmaceutical industry enters 2021 with a new sense of purpose. Pharma pivots East.
Expert insights. Personalized for you.
52 
Let's personalize your content